Bipolar Disorder (BPD) Approved Drugs
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Bipolar Disorder (BPD).
Found 8 Approved Drugs for Bipolar Disorder (BPD)
OLANZapine
Brand Names
Zyprexa, Lybalvi, Symbyax, Zyprexa Zydis, Fluoxetine, Prozac
OLANZapine
Brand Names
Zyprexa, Lybalvi, Symbyax, Zyprexa Zydis, Fluoxetine, Prozac
Form: Liquid, Injection, Tablet, For, Capsule, Solution
Method of administration: Oral, Intramuscular
FDA approval date: February 01, 1988
Classification: Atypical Antipsychotic
Fluoxetine tablets are indicated for the treatment of: Major Depressive Disorder (MDD). The efficacy of fluoxetine in MDD was established in one 5-week trial, three 6-week trials, and one maintenance study in adults. The efficacy of fluoxetine was also established in two 8- to 9-week trials in pediatric patients 8 to 18 years of age [see Clinical Studies ( 1.
LamoTRIgine
Brand Names
Lamictal ODT, Subvenite
LamoTRIgine
Brand Names
Lamictal ODT, Subvenite
Form: Tablet, Kit
Method of administration: Oral
FDA approval date: January 23, 2009
Classification: Anti-epileptic Agent
Lamotrigine is indicated for: Epilepsy — adjunctive therapy in patients aged 2 years and older: Partial-onset seizures. primary generalized tonic-clonic seizures. generalized seizures of Lennox-Gastaut syndrome.
RisperiDONE
Brand Names
Risperdal, Risperdal M-TAB, Risperdal Consta, Perseris, Rykindo, UZEDY
RisperiDONE
Brand Names
Risperdal, Risperdal M-TAB, Risperdal Consta, Perseris, Rykindo, UZEDY
Form: Injection, Tablet, Kit, Solution
Method of administration: Subcutaneous, Oral
FDA approval date: December 29, 1993
Classification: Atypical Antipsychotic
Risperidone orally disintegrating tablets are atypical antipsychotic indicated for: Treatment of schizophrenia.
Geodon
Generic Name
Ziprasidone
Geodon
Generic Name
Ziprasidone
Form: Injection, Capsule
Method of administration: Oral, Intramuscular
FDA approval date: December 23, 2003
Classification: Atypical Antipsychotic
Ziprasidone is indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [see Warnings and Precautions.
Showing 1-5 of 8
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances